A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

Interim results from the RELATIVITY cohort confirm high effectiveness and safety of LAI cabotegravir plus rilpivirine in Spanish clinical practice, consistent with randomized trial outcomes and real-world data. An extended follow-up will provide further insights.

Authors

Institutions

Publication Details

Journal
Journal of Antimicrobial Chemotherapy
Published
2025-10-02
DOI
https://doi.org/10.1093/jac/dkaf389
Citations
1
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

Roberto Pedrero‐Tomé, Oscar Luis Ferrero, M. Guisado Clavero, B Valentin et al.
1 citations
Journal of Antimicrobial Chemotherapy
HIV/AIDS Research and Interventions
1.40
article

A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

Roberto Pedrero‐Tomé, Oscar Luis Ferrero, M. Guisado Clavero, B Valentin, Miguel Alberto de Zárraga, Beatriz de la Calle, Luís Morano, Alfonso Cabello, M García-Navarro, Adrián Rodríguez, María Jesús Vivancos, Marisa Montes, Luís Buzón, Juan Tiraboschi, Miriam Estébanez, Francisco Fanjul, Rubén A. Cabo, Juan Carlos Gainzarain, Laura Gisbert, Jesús Troya, Noemí Cabello‐Clotet, Hadrián Pernas, Juan Emilio Losa, Cristina Escrich, Marta Millán, Ana Lérida, David Vinuesa García, Carmen Hidalgo‐Tenorio, Christian Andrés, Cristina Díez, Alberto Romero-Palacios, Noemí Ramos, Mireia Santacreu-Guerrero, María José Crusells, Francisco Arnaíz de las Revillas, María del Carmen Navarro, Patricia Barragán, José Sanz, Mar Masiá, Miguel Torralba, Míkel Del Álamo, María Remedios Alemán Valls, Ruth Calderón, Antonio Jesús Sánchez-Guirao, Eva Maria Luiz Ferreira, Jara Llenas‐García, Alberto Díaz de Santiago, María Antonia Sepúlveda, A Michavila Gómez, Bárbara Alonso, Enrique Bernal, María del Carmen Montero, María Aguilera, Marı́a José Galindo, María Ángeles Garcinuño, Rosa María Martínez-Álvarez, Miguel Egido, Juan José Corte
article en
1 citations

Abstract

Interim results from the RELATIVITY cohort confirm high effectiveness and safety of LAI cabotegravir plus rilpivirine in Spanish clinical practice, consistent with randomized trial outcomes and real-world data. An extended follow-up will provide further insights.

Journal of Antimicrobial ChemotherapyVol. 80(12)
Universitat de Miguel Hernández d'Elx (ES), Catholic University of Ávila (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Instituto de Salud Carlos III (ES), Hospital de Sant Pau (ES), Bellvitge University Hospital (ES), ProMedica Toledo Hospital (US), University Hospital Complex Of Vigo (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Clínico San Carlos (ES), Hospital General De Segovia (ES), Hospital Universitario San Agustín (ES), Hospital Son Llatzer (ES), Hospital Universitario de Torrejón (ES), Hospital General Universitario Morales Meseguer (ES), Hospital de Basurto (ES), Hospital General Nuestra Señora del Prado (ES), Hospital Terrassa (ES), Hospital Universitario de Guadalajara (ES), Hospital Clínico Universitario de Valencia (ES), University Hospital Mútua de Terrassa (ES), Hospital de Viladecans (ES), Marqués de Valdecilla University Hospital (ES), Pius Hospital de Valls (ES), Hospital Universitario Fundación Alcorcón (ES), Hospital Universitario 12 De Octubre (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Doctor José Molina Orosa (ES), Hospital Universitario Príncipe de Asturias (ES), Fundación Hospital de Jove (ES), Hospital Universitario Araba (ES), Fundación Marques de Valdecilla (ES), Hospital Obispo Polanco (ES), Instituto de Investigación Biosanitaria de Granada (ES), Hospital Universitario Miguel Servet (ES), Hospital Universitario de Burgos (ES), Hospital General Universitario de Elche (ES), Hospital Universitario Virgen de las Nieves (ES), Hospital Santa Caterina (ES), Hospital de Sabadell (ES), Hospital Universitario del Sureste (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Mútua Terrassa (ES), Hospital Reina Sofía de Murcia (ES), Hospital Universitario de La Princesa (ES), Hospital Universitario Central de Asturias (ES), Hospital Clínico Universitario Lozano Blesa (ES), Hospital de Cruces (ES), Hospital Universitario del Vinalopó (ES), Hospital Universitario Puerto Real (ES), Hospital Universitario de Fuenlabrada (ES), Hospital Universitario De Cabueñes (ES), Hospital Vega Baja (ES), Hospital Universitari de Tortosa Verge de la Cinta (ES), Hospital Universitario Son Espases (ES), Hospital General San Jorge (ES), Hospital Marina Baixa (ES), Hospital Universitario Río Hortega (ES), Complejo Hospitalario de Pontevedra (ES), Hospital Universitario Ramón y Cajal (ES), Complejo Hospitalario Universitario de Toledo (ES), Hospital Central de la Defensa Gómez Ulla (ES), Hospital Universitario Infanta Leonor (ES), Universidad Autónoma de Madrid (ES)
Openalex Percentile: Top 15%
HIV/AIDS Research and Interventions
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.